Payment overview · 2025
General Payments
$371.17
3 reported records · 3 companies
Healthcare provider profile · identity verified
Edgar M. Conrad, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · JOPLIN, MO · NPI 1124055074
Verified facts
What the public records show
CMS Open Payments records show Edgar M. Conrad, D.O. received $371.17 in general payments during 2025 across 3 reported records.
Axsome Therapeutics, Inc. accounted for 33.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 42 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $124.63 | 33.6% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $123.61 | 33.3% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $122.93 | 33.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $371.17 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $124.63 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $123.61 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $122.93 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 42 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
42 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 617 | 113 |
| Levothyroxine Sodium | Levothyroxine Sodium | 508 | 92 |
| Gabapentin | Gabapentin | 483 | 76 |
| Eliquis | Apixaban | 482 | 49 |
| Potassium Chloride | Potassium Chloride | 427 | 79 |
| Amlodipine Besylate | Amlodipine Besylate | 401 | 77 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 359 | 57 |
| Furosemide | Furosemide | 342 | 77 |
| Omeprazole | Omeprazole | 313 | 60 |
| Metformin Hcl | Metformin Hcl | 302 | 45 |
| Sertraline Hcl | Sertraline Hcl | 302 | 44 |
| Alprazolam | Alprazolam | 277 | 43 |
| Lisinopril | Lisinopril | 268 | 51 |
| Tramadol Hcl | Tramadol Hcl | 266 | 46 |
| Tamsulosin Hcl | Tamsulosin Hcl | 257 | 42 |
| Januvia | Sitagliptin Phosphate | 253 | 15 |
| Trazodone Hcl | Trazodone Hcl | 241 | 42 |
| Pantoprazole Sodium | Pantoprazole Sodium | 239 | 59 |
| Jardiance | Empagliflozin | 232 | 22 |
| Carvedilol | Carvedilol | 227 | 48 |
| Myrbetriq | Mirabegron | 223 | 18 |
| Olanzapine | Olanzapine | 207 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 193 | 43 |
| Losartan Potassium | Losartan Potassium | 189 | 35 |
| Donepezil Hcl | Donepezil Hcl | 178 | 30 |
| Divalproex Sodium | Divalproex Sodium | 170 | 19 |
| Memantine Hcl | Memantine Hcl | 169 | 23 |
| Ondansetron Hcl | Ondansetron Hcl | 153 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 152 | 32 |
| Levetiracetam | Levetiracetam | 147 | 23 |
| Baclofen | Baclofen | 145 | 16 |
| Duloxetine Hcl | Duloxetine Hcl | 144 | 24 |
| Mirtazapine | Mirtazapine | 132 | 31 |
| Zolpidem Tartrate | Zolpidem Tartrate | 127 | 16 |
| Metoprolol Succinate | Metoprolol Succinate | 119 | 33 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 118 | 60 |
| Citalopram Hbr | Citalopram Hydrobromide | 110 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 108 | 21 |
| Simvastatin | Simvastatin | 104 | 23 |
| Montelukast Sodium | Montelukast Sodium | 101 | 26 |
| Oxycodone Hcl | Oxycodone Hcl | 99 | 16 |
| Tradjenta | Linagliptin | 99 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 96 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 95 | 19 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 91 | 23 |
| Finasteride | Finasteride | 89 | 17 |
| Prednisone | Prednisone | 89 | 36 |
| Meloxicam | Meloxicam | 87 | 17 |
| Risperidone | Risperidone | 85 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 84 | 17 |
| Aripiprazole | Aripiprazole | 82 | 13 |
| Bumetanide | Bumetanide | 79 | 15 |
| Lorazepam | Lorazepam | 79 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 77 | 15 |
| Vraylar | Cariprazine Hcl | 76 | suppressed |
| Allopurinol | Allopurinol | 73 | 16 |
| Escitalopram Oxalate | Escitalopram Oxalate | 73 | 19 |
| Metformin Hcl Er | Metformin Hcl | 73 | 12 |
| Xarelto | Rivaroxaban | 73 | suppressed |
| Famotidine | Famotidine | 70 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 70 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 67 | 32 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 67 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 64 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 64 | 38 |
| Lacosamide | Lacosamide | 63 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 61 | 30 |
| Benztropine Mesylate | Benztropine Mesylate | 61 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 57 | suppressed |
| Levofloxacin | Levofloxacin | 57 | 40 |
| Ondansetron Odt | Ondansetron | 57 | 13 |
| Diltiazem 24hr Er | Diltiazem Hcl | 56 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 56 | suppressed |
| Topiramate | Topiramate | 56 | suppressed |
| Nystatin | Nystatin | 55 | 21 |
| Ropinirole Hcl | Ropinirole Hcl | 55 | suppressed |
| Gemfibrozil | Gemfibrozil | 54 | suppressed |
| Glimepiride | Glimepiride | 54 | suppressed |
| Sucralfate | Sucralfate | 54 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 53 | 32 |
| Dicyclomine Hcl | Dicyclomine Hcl | 53 | 12 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 52 | 23 |
| Pregabalin | Pregabalin | 52 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 50 | 25 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 50 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 49 | suppressed |
| Spironolactone | Spironolactone | 48 | 14 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 19 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 45 | suppressed |
| Bupropion Xl | Bupropion Hcl | 45 | suppressed |
| Linzess | Linaclotide | 45 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 45 | suppressed |
| Diazepam | Diazepam | 42 | 11 |
| Rexulti | Brexpiprazole | 42 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 42 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 41 | 21 |
| Ezetimibe | Ezetimibe | 41 | 12 |
| Latanoprost | Latanoprost | 41 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 40 | 14 |
| Novolog Flexpen | Insulin Aspart | 40 | suppressed |
| Temazepam | Temazepam | 39 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 38 | suppressed |
| Entresto | Sacubitril/Valsartan | 37 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 37 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 36 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 36 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 35 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 34 | 14 |
| Cephalexin | Cephalexin | 34 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 34 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 34 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 33 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 33 | 14 |
| Metoclopramide Hcl | Metoclopramide Hcl | 33 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 18 |
| Bupropion Hcl Sr | Bupropion Hcl | 32 | suppressed |
| Trulicity | Dulaglutide | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 31 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 29 | 13 |
| Vascepa | Icosapent Ethyl | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 28 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 28 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 28 | suppressed |
| Novolog | Insulin Aspart | 28 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 27 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | suppressed |
| Glipizide | Glipizide | 26 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 26 | suppressed |
| Metolazone | Metolazone | 26 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 25 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 25 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 25 | suppressed |
| Nifedipine Er | Nifedipine | 25 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Paliperidone Er | Paliperidone | 25 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 24 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 23 | suppressed |
| Torsemide | Torsemide | 23 | suppressed |
| Atenolol | Atenolol | 22 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 22 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 21 | suppressed |
| Insulin Lispro | Insulin Lispro | 20 | suppressed |
| Lovastatin | Lovastatin | 20 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 20 | suppressed |
| Valsartan | Valsartan | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Levemir | Insulin Detemir | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Prenatal Vitamin Plus Low Iron | Pnv,calcium 72/Iron/Folic Acid | 19 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 19 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 17 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 17 | suppressed |
| Acetylcysteine | Acetylcysteine | 16 | suppressed |
| Calcitriol | Calcitriol | 16 | suppressed |
| Clonazepam | Clonazepam | 16 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 16 | suppressed |
| Ozempic | Semaglutide | 16 | suppressed |
| Sotalol Af | Sotalol Hcl | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Enulose | Lactulose | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Haloperidol | Haloperidol | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Nyamyc | Nystatin | 15 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Indomethacin | Indomethacin | 14 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 14 | suppressed |
| Primidone | Primidone | 14 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 13 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 13 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 13 | suppressed |
| Scopolamine | Scopolamine | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 12 | suppressed |
| Febuxostat | Febuxostat | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Mirabegron Er | Mirabegron | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Savella | Milnacipran Hcl | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Auryxia | Ferric Citrate | 11 | suppressed |
| Austedo | Deutetrabenazine | 11 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 11 | suppressed |
| Insulin Aspart | Insulin Aspart | 11 | suppressed |
| Insulin Degludec Pen (U-100) | Insulin Degludec | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | suppressed |
| Oxycontin | Oxycodone Hcl | 11 | suppressed |
| Pimozide | Pimozide | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 11 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $371.17 · 3 records | Axsome Therapeutics, Inc. | Auvelity, INGREZZA, REXULTI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error